Clinical Trial

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
This study is a prospective, non-randomized clinical study aimed at investigating the potential benefits of continuous positive airway pressure (CPAP) support during radiotherapy for breast cancer. CPAP is a device commonly used to support breathing, for example in patients with sleep apnea. The investigators expect a reduction in radiation doses to the heart and/or lungs with CPAP-supported radiotherapy compared to standard radiotherapy (without CPAP), which may also lead to a decrease in radiation-induced heart and/or lung conditions in the long term. The study will also examine how the use of a CPAP device can be implemented in daily radiotherapy practice.
Trial Details
NCT Number NCT07373782
Lead Sponsor Universitaire Ziekenhuizen KU Leuven
Collaborators: VitalAire
Conditions Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Enrollment 53 participants
Start Date 2025-02-11
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-28